G. E. van der Kraaij

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

Alexander Nast, Catherine Smith, Phyllis I. Spuls et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 389 citations · Full text

Medicine, Dermatology, Pharmacotherapy +11

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

Alexander Nast, Catherine Smith, Phyllis I. Spuls et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 211 citations · Full text

Medicine, Clinical Sciences, Dermatology +11

European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – <scp>EDF</scp> in cooperation with <scp>EADV</scp> and <scp>IPC</scp>

Alexander Nast, Phyllis I. Spuls, G. E. van der Kraaij et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 135 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study

J.M.P.A. van den Reek, Lieke J. van Vugt, Martijn B. A. van Doorn et al. · Acta Dermato Venereologica · 2018 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial

G. E. van der Kraaij, Celine Busard, J. M. P. A. van den Reek et al. · Journal of Investigative Dermatology · 2022 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17